These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20811786)

  • 1. The persistent challenge of lupus nephritis.
    Valesini G; Conti F
    Clin Rev Allergy Immunol; 2011 Jun; 40(3):135-7. PubMed ID: 20811786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lupus-nephritis--diagnosis and treatment].
    Norby GE; Lerang K; Holdaas H; Gran JT; Strøm EH; Draganov B; Os I; Hartmann A; Gilboe IM
    Tidsskr Nor Laegeforen; 2010 Jun; 130(11):1140-4. PubMed ID: 20531500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of lupus nephritis.
    D'Cruz DP; Hughes GR
    BMJ; 2005 Feb; 330(7488):377-8. PubMed ID: 15718519
    [No Abstract]   [Full Text] [Related]  

  • 4. Nonrenal disease activity following mycophenolate mofetil or intravenous cyclophosphamide as induction treatment for lupus nephritis: findings in a multicenter, prospective, randomized, open-label, parallel-group clinical trial.
    Ginzler EM; Wofsy D; Isenberg D; Gordon C; Lisk L; Dooley MA;
    Arthritis Rheum; 2010 Jan; 62(1):211-21. PubMed ID: 20039429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Manifestation of diffuse proliferative lupus nephritis in a patient treated with long-term mycophenolate mofetil].
    Sixdorf U; Bauer H; Märker-Hermann E
    Dtsch Med Wochenschr; 2006 Oct; 131(41):2266-9. PubMed ID: 17036267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacotherapy of SLE].
    Nakazawa T; Kumagai S; Kogata Y
    Nihon Rinsho; 2005 May; 63 Suppl 5():253-9. PubMed ID: 15954358
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent news in the treatment of lupus nephritis.
    Tesar V; Hruskova Z
    Minerva Med; 2012 Aug; 103(4):235-51. PubMed ID: 22805617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rituximab, a viable alternative for induction therapy of active lupus nephritis.
    Zhou XJ; Zhao MH; Zhang H
    Rheumatology (Oxford); 2014 Sep; 53(9):1537-8. PubMed ID: 24729446
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful treatment of combined proliferative and membranous lupus nephritis using a full corticosteroid-free regimen.
    Tedeschi B; Arnaud L; Hie M; Mathian A; Amoura Z
    Ann Rheum Dis; 2014 Feb; 73(2):474-5. PubMed ID: 24001887
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment options for proliferative lupus nephritis: an update of clinical trial evidence.
    Navaneethan SD; Viswanathan G; Strippoli GF
    Drugs; 2008; 68(15):2095-104. PubMed ID: 18840001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent progress in the treatment of lupus nephritis.
    Fanouriakis A; Krasoudaki E; Tzanakakis M; Boumpas DT
    Mod Rheumatol; 2012 Nov; 22(6):803-13. PubMed ID: 22584472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-CD20 antibody treatment in refractory Class IV lupus nephritis.
    Carroll RP; Brown F; Kerr PG
    Nephrol Dial Transplant; 2007 Jan; 22(1):291-3. PubMed ID: 17095581
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G; Danza A; Khamashta M
    Med Clin (Barc); 2013 Dec; 141(12):533-42. PubMed ID: 23622892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction and maintenance treatment of proliferative lupus nephritis: a meta-analysis of randomized controlled trials.
    Henderson LK; Masson P; Craig JC; Roberts MA; Flanc RS; Strippoli GF; Webster AC
    Am J Kidney Dis; 2013 Jan; 61(1):74-87. PubMed ID: 23182601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New and future therapies for lupus nephritis.
    Appel GB
    Cleve Clin J Med; 2012 Feb; 79(2):134-40. PubMed ID: 22301564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis.
    Marks SD; Tullus K
    Acta Paediatr; 2010 Jul; 99(7):967-74. PubMed ID: 20222881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current and novel therapeutics in the treatment of systemic lupus erythematosus.
    Yildirim-Toruner C; Diamond B
    J Allergy Clin Immunol; 2011 Feb; 127(2):303-12; quiz 313-4. PubMed ID: 21281862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy and safety of rituximab in patients with active proliferative lupus nephritis: the Lupus Nephritis Assessment with Rituximab study.
    Rovin BH; Furie R; Latinis K; Looney RJ; Fervenza FC; Sanchez-Guerrero J; Maciuca R; Zhang D; Garg JP; Brunetta P; Appel G;
    Arthritis Rheum; 2012 Apr; 64(4):1215-26. PubMed ID: 22231479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on Lupus Nephritis: Core Curriculum 2020.
    Parikh SV; Almaani S; Brodsky S; Rovin BH
    Am J Kidney Dis; 2020 Aug; 76(2):265-281. PubMed ID: 32220510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human clinical trials in lupus nephritis.
    Dooley MA; Falk RJ
    Semin Nephrol; 2007 Jan; 27(1):115-27. PubMed ID: 17336693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.